Discovery of Ximelagatran in an Historical Perspective
Seminars in Vascular Medicine · 01.01.2005 · 5 (03) · 227-234
DOI: 10.1055/s-2005-916161 ↗Kurz gefasst
Historischer Beitrag in der Zeitschrift Seminars in Vascular Medicine, erschienen am 01.01.2005. Verfasst von David Gustafsson. Beteiligte Einrichtung: Department of Cardiovascular Pharmacology, AstraZeneca R&D, Mölndal, Sweden. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
The oral direct thrombin inhibitor ximelagatran is the first oral anticoagulant since the introduction of the vitamin K antagonists in the early 1940s. A comparison of the discovery and early clinical development of the two classes of oral anticoagulants reveals some similarities but also several differences that illustrate the change in drug discovery over the last half century.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Pharmacology, AstraZeneca R&D, Mölndal, Sweden.
Zitieren
APA
Gustafsson, D. (2005). Discovery of Ximelagatran in an Historical Perspective. Seminars in Vascular Medicine, 5(03), 227-234. https://doi.org/10.1055/s-2005-916161
Vancouver
Gustafsson D. Discovery of Ximelagatran in an Historical Perspective. Seminars in Vascular Medicine. 2005;5(03):227-234. doi:10.1055/s-2005-916161
BibTeX
@article{Gustafsson2005,
author = {Gustafsson, David},
title = {Discovery of Ximelagatran in an Historical Perspective},
journal = {Seminars in Vascular Medicine},
year = {2005},
volume = {5},
number = {03},
pages = {227--234},
doi = {10.1055/s-2005-916161}
}
EUVIMED